Medexus Pharmaceuticals Inc.
MDP.TOTSXHealthcare● Active
$3.95
+$0.04(+1.02%)
Market Cap$127586501
P/E Ratio—
52W High$4.17
52W Low$2.47
Medexus Pharmaceuticals Inc.（MDP.TO）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · MDP.TO · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.02B | $0.01B | $0.01B | $0.01B | $0.02B |
| Net Receivables | $0.01B | $0.02B | $0.03B | $0.01B | $0.02B |
| Inventory | $0.04B | $0.03B | $0.02B | $0.02B | $0.01B |
| Total Current Assets | $0.08B | $0.07B | $0.07B | $0.05B | $0.06B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Intangible Assets | $0.07B | $0.06B | $0.07B | $0.08B | $0.08B |
| Total Assets | $0.17B | $0.16B | $0.16B | $0.14B | $0.15B |
| Liabilities | |||||
| Short-Term Debt | $0.04B | $0.02B | $0.04B | $0.02B | $0.01B |
| Accounts Payable | $0.01B | $0.01B | $0.01B | $0.02B | $0.01B |
| Total Current Liabilities | $0.10B | $0.07B | $0.08B | $0.05B | $0.04B |
| Long-Term Debt | $0.00B | $0.03B | $0.03B | $0.04B | $0.03B |
| Total Liabilities | $0.12B | $0.13B | $0.14B | $0.12B | $0.13B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.06B) | ($0.06B) | ($0.06B) | ($0.07B) | ($0.06B) |
| Total Stockholders Equity | $0.05B | $0.03B | $0.02B | $0.02B | $0.02B |
| Total Liab & Equity(computed) | $0.17B | $0.16B | $0.16B | $0.14B | $0.15B |
| Debt Summary | |||||
| Total Debt | $0.04B | $0.05B | $0.07B | $0.05B | $0.04B |
| Net Debt | $0.01B | $0.04B | $0.08B | $0.04B | $0.03B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Medexus Pharmaceuticals Inc.
关于Medexus Pharmaceuticals Inc.（MDP.TO）资产负债表
Medexus Pharmaceuticals Inc.总资产$0.17B，现金及短期投资$0.02B，总负债$0.12B，总债务$0.04B，股东权益$0.05B。
常见问题
MDP.TO · 4 问Medexus Pharmaceuticals Inc.总债务$0.04B，净债务$0.01B。
MDP.TO total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10